InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Flynn Patrick John, 董事. Insider active across 1 company, notably NRX Pharmaceuticals, Inc.. Aggregated, 2 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €3k. History available since 28 November 2022. The latest transaction was filed on 28 November 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Patrick John Flynn is a Director at NRX Pharmaceuticals, Inc. As a board member, he contributes to the governance of the company and strategic decision-making. His experience in the pharmaceutical sector allows him to provide informed perspectives on the challenges and opportunities faced by the company. He plays a key role in guiding strategies aimed at ensuring the growth and sustainability of NRX Pharmaceuticals.